Santiago Durán García

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes

Bernard Zinman, Byron J. Hoogwerf, Santiago Durán García et al. · Annals of Internal Medicine · 2007 · 429 citations

Medicine, Pharmacology, Pharmacotherapy +17

Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes

Elisabeth R. Mathiesen, Moshe Hod, Marina Ivanišević et al. · Diabetes Care · 2012 · 217 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study

Elisabeth R. Mathiesen, Norsiah Ali, Amra Ciric Alibegovic et al. · Diabetes Care · 2021 · 27 citations · Full text

Public Health, Endocrinology, Obstetrics +16